Krajina: Austrália
Jazyk: angličtina
Zdroj: APVMA (Australian Pesticides and Veterinary Medicines Authority)
FELINE CALICIVIRUS - INACTIVATED; CHLAMYDOPHILIA FELIS INACTIVATED; FELINE LEUKAEMIA VIRUS - INACTIVATED; FELINE PANLEUCOPENIA VIRUS - INACTIVATED; FELINE RHINOTRACHEITIS VIRUS - INACTIVATED; AMPHOTERICIN; NEOMYCIN; POLYMYXIN B; THIOMERSAL
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
feline rhinotracheitis+feline calicivirus+feline parvovirus + others
MISC. VACCINES OR ANTI SERA
FELINE CALICIVIRUS - INACTIVATED VACCINE-VIRAL Active 0.0 P; CHLAMYDOPHILIA FELIS INACTIVATED VACCINE-VIRAL Active 0.0 P; FELINE LEUKAEMIA VIRUS - INACTIVATED VACCINE-VIRAL Active 0.0 P; FELINE PANLEUCOPENIA VIRUS - INACTIVATED VACCINE-VIRAL Active 0.0 P; FELINE RHINOTRACHEITIS VIRUS - INACTIVATED VACCINE-VIRAL Active 0.0 P; AMPHOTERICIN ANTIBIOTIC Other 0.32 ug/ml; NEOMYCIN ANTIBIOTIC Other 4.0 ug/ml; POLYMYXIN B ANTIBIOTIC Other 14.0 IU/ml; THIOMERSAL MERCURY Other 18.0 ug/ml
10 x 1mL vials; 25 x 1mL vials
VM - Veterinary Medicine
CAT - OVER 8 WEEKS OF AGE
IMMUNOTHERAPY
FELINE CALICIVIRUS | FELINE CHLAMYDIA PSITTACI | FELINE ENTERITIS | FELINE LEUKAEMIA VIRUS | FELINE RHINOTRACHEITIS | CALICIVIRUS (FELINE) | DISEASE CAUSED BY | ENTERITIS (FELINE) | FCV | FELINE HERPESVIRUS TYPE 1 | FELINE INFECTIOUS ENTERITIS | FELINE PANLEUCOPENIA (FP) | FHV-1 | FVR | HERPESVIRUS 1 (FELINE) | HERPESVIRUS TYPE 1 (FELINE) | PANLEUCOPENIA (FELINE) | RHINOTRACHEITIS (FELINE)
Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: CAT - OVER 8 WEEKS OLD: [FELINE CALICIVIRUS, FELINE CHLAMYDIA PSITTACI, FELINE ENTERITIS, FELINE LEUKAEMIA VIRUS, FELINE RHINOTRACHEITIS]; For the active immunisation of healthy cats 8 weeks of age or older to aid in the reduction of clinical symptoms caused by infection with feline rhinotracheitis virus, feline calicivirus, panleucopenia virus, Chlamydophila felis and feline leukaemia virusSee Precaution/ Side effects information on label. This vaccine does not prevent infection or shedding.
Registered
2023-07-01
READ SAFETY DIRECTIONS FOR ANIMAL TREATMENT ONLY FEL-0-VAX® 5 VACCINE (INACTIVATED) Contents: 1 dose Vial label Fei-0-Vax 5 Vaccine (Inactivated) APVMA51366 Page 1 of 5 8 October 2013 + RLP Approved TO BE USED BY, OR UNDER THE DIRECTION OF A REGISTERED VETERINARY SURGEON. READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. Store between 2-8°C. Do not freeze. Protect from light. APVMA 51366/57811 Batch No.: Expiry: Boehringer lngelheim Tray label- 10 READ SAFETY DIRECTIONS FOR ANIMAL TREATMENT ONLY FEL-0-VAX® 5 VACCINE (INACTIVATED) ACTIVE CONSTITUENTS: Fei-0-Vax 5 Vaccine (Inactivated) APVMA51366 Page 2 of 5 8 October 2013 Inactivated feline rhinotracheitis virus (FVR 605, RP ~ 1.0), feline calicivirus (FCV 255, RP ~ 1.0), panleucopenia virus (FPV CU-4, RP ~ 1.0), Chlamydophifa fefis (CELLO, RP 2! 1.0) and feline leukaemia virus (1161 E, RP" 1.0), amphotericin, polymyxin B, neomycin and thiomersal ( <0.05% w/v) added as preservatives. Contents: 1 0 single dose vials An inactivated vaccine for the active immunisation of healthy cats 8 weeks of age or older to aid in the reduction of clinical symptoms caused by infection with feline rhinotracheitis virus, feline calicivirus, panleucopenia virus, Chfamydophifa felis and feline leukaemia virus. This vaccine does not prevent infection or shedding. TO BE USED BY, OR UNDER THE DIRECTION OF A REGISTERED VETERINARY SURGEON. READ ENCLOSED LEAFLET BEFORE USING THIS PRODUCT DOSE: Withdraw the contents of a single dose vial (1 mL) aseptically into a sterile syringe and inject subcutaneously. Store between 2-8°C. Do not freeze. Protect from light. APVMA No. 51366/57811 Batch No.: Expiry: Fei-0-Vax® 5 is a registered trademark of Boehringer lngelheim Vetmedica Inc.- used under LICENSE. Please recycle leaflet, label and tray only. Boehringer lngelheim Tray label - 25 READ SAFETY DIRECTIONS FOR ANIMAL TREATMENT ONLY FEL-0-VAX® 5 VACCINE (INACTIVATED) ACTIVE CONSTITUENTS: Fei-0-Vax 5 Vaccine (Inactivated) APVMA51366 Page 3 of 5 8 October 2013 Inactivated feline rhinotrachei Prečítajte si celý dokument
CS: 1.9.46 Page: 1 MATERIAL SAFETY DATA SHEET 4 of Infosafe No™ LQ088 August 2011 ISSUED by BOEHRING Issue Date : FEL-O-VAX® 5 VACCINE (INACTIVATED) Product Name : Not classified as hazardous 1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER FEL-O-VAX® 5 VACCINE (INACTIVATED) PRODUCT NAME Boehringer Ingelheim Pty. Limited COMPANY NAME 78 Waterloo Rd North Ryde NSW 2113 Australia ADDRESS 1800 038 037 EMERGENCY TEL. Tel: 1800 038 037 Fax: +61 2 8875 8715 TELEPHONE/FAX NUMBER animalhealth.au@boehringer-ingelheim.com EMAIL An inactivated vaccine for the active immunisation of healthy cats 8 weeks of age or older to aid in the reduction of clinical symptoms caused by infection with feline rhinotracheitis virus, panleucopenia virus, feline calicivirus, feline leukaemia virus and Chlamydophila felis. RECOMMENDED USE 2. HAZARDS IDENTIFICATION Not classified as hazardous NON-HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS. Not Classified as Hazardous according to criteria of National Occupational Health & Safety Commission, Australia (NOHSC). Not Classified as Dangerous Goods according to the Australian Code for the Transport of Dangerous Goods by Road and Rail. (7th edition) HAZARD CLASSIFICATION 3. COMPOSITION/INFORMATION ON INGREDIENTS Each 1mL contains inactivated feline rhinotracheitis virus, inactivated feline calicivirus, inactivated feline panleucopenia virus, inactivated feline leukaemia virus and inactivated feline Chlamydophila felis (each at relative potency of > 1). Amphotericin, polymyxin B, neomycin and thiomersal added as preservatives. INFORMATION ON COMPOSITION NAME RISK PHRASE CAS PROPORTION HAZARD SYMBOL INGREDIENTS Ingredients determined not to be hazardous - Balance Live virus vaccine - 4. FIRST AID MEASURES No special precautions required. However, if inhaled, remove affected person from contaminated area. Keep at rest until recovered. If symptoms persist seek medical attention. INHALATION Do not induce vomiting. Wash out mouth thoroughly with water. If symptoms develop seek medical attention. INGESTION W Prečítajte si celý dokument